Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05880849Phase 1Completed

Choline Effects - Pre-symptomatic AD

Role: collaborator

NCT06154174Not ApplicableRecruiting

Choline to Improve Malnutrition and Enhance Cognition

Role: collaborator

NCT07264257Not ApplicableCompleted

Choline and Brain Functioning in Postmenopausal Women

Role: collaborator

NCT06837246Not ApplicableRecruiting

A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

Role: collaborator

NCT03194659Not ApplicableUnknown

Synergy Between Choline and DHA

Role: collaborator

All 5 trials loaded